Introduction {#sec1-1}
============

Chronic kidney disease has become epidemic in HIV/AIDS patients worldwide, especially being common in Black population.\[[@ref1]\] Kidney pathology is broadly divided into glomerular disease, tubulointerstitial, and vascular diseases.\[[@ref2]\] Glomerular disease directly related to HIV infection, HIV-associated nephropathy (HIVAN), is well established in North America, Africa and Western Europe.\[[@ref3]\] In Western and African studies up to 60% of all renal biopsies performed for HIV positive patients reveal HIVAN. HIVAN is a collapsing form of focal glomerulosclerosis (FSGS) associated with microcystic dilatation and tubulointerstitial injury. It usually presents with rapidly progressing renal dysfunction and high-grade proteinuria, often associated with high mortality.\[[@ref4]\] The incidence of HIVAN has declined since the introduction of cART (combination antiretroviral therapy), whereas incidence of non-HIV-associated chronic kidney diseases (CKD) has increased.\[[@ref5]\]

In view of high burden of renal diseases in HIV-infected patients, the Infectious Diseases Society of America (IDSA) recommends screening for kidney disease using urinalysis and estimation of renal function.\[[@ref6]\] These guidelines further recommend proteinuria assessment using quantitative methods to allow earlier identification of potential kidney disease. Renal biopsy is advocated wherever feasible, because the treatment options and prognosis are influenced by the actual histological diagnosis. While HIVAN has been reported consistently in Western studies, the prevalence in studies from Asia has been found to low/absent.\[[@ref7][@ref8]\] The available studies from India differ strikingly, with some studies showing presence of HIVAN,\[[@ref9][@ref10][@ref11]\] whereas others reporting complete absence of this entity.\[[@ref8][@ref12][@ref13]\] With this perspective, the present study was carried out to elucidate the histological spectrum of renal disease in HIV patients from a tertiary care center from India. Kidney biopsies were performed in HIV patients with proteinuria ≥1 g/day, to delineate the glomerular lesions including presence of possible HIVAN.

Materials and Methods {#sec1-2}
=====================

Study population and protocol {#sec2-1}
-----------------------------

This was a single center observational study done at the Institute of Medical Sciences (IMS), Banaras Hindu University (BHU), Varanasi, India. All consecutive HIV positive patients of ≥18 years of age, admitted in general medicine or nephrology departments, were included in the study. The participants were subjected to detailed history, physical examination, and laboratory investigation. The urine was tested using standard dipstick method for screening of proteinuria. The patients having a dipstick proteinuria of 1+ or more were subjected to quantitative 24-hour urinary protein estimation. Percutaneous ultrasound-guided kidney biopsy was done in patients with proteinuria of ≥1 g/day. The study was conducted according to the Helsinki Declaration and the Good Clinical Practice Guidelines. Written informed consent was obtained from all patients. Ethical approval for the study protocol was obtained from Ethics Committee of IMS, BHU.

Kidney biopsy and histopathology {#sec2-2}
--------------------------------

Kidney biopsy was done in HIV positive patients with proteinuria of ≥1 g/day, after proper counseling and taking written informed consent. Biopsy was contraindicated in patients with small/contracted kidneys, single kidney, polycystic kidney disease, hydronephrosis, and presence of urinary tract infection. Blood pressure was adequately controlled in hypertensive patients before biopsy. Biopsy was performed under ultrasound guidance with a biopsy gun (BARD 16/18 G, 22 mm, cutting edge) with the use of local anesthesia. The patients were discharged after observation for 6 hours, if the urine was clear. Two cores were taken by biopsy and the tissue was placed in 10% formalin for light microscopic (LM) examination. The tissue was studied using H and E (hematoxylin and eosin), PAS (periodic acid Schiff), and AFOG (acid fuschin orange green) stains. Immunofluorescence (IF) and electron microscopy (EM) was not done as per the institute\'s policy.

Definitions {#sec2-3}
-----------

Diagnosis of HIV and AIDS were based on 1993 revised classification system by CDC (Centers for Disease Control).\[[@ref14]\] CKD was defined as kidney damage (structural or functional abnormalities of the kidney) or estimated glomerular filtration rate (eGFR) \<60 mL/min/1.73 m^2^ for 3 months or more, irrespective of cause.\[[@ref15]\] Significant proteinuria for the purpose of kidney biopsy was defined as ≥1 g/day. Nephrotic range proteinuria was defined as a 24-hour urine protein ≥3.5 g/day.

Results {#sec1-3}
=======

Study population {#sec2-4}
----------------

A total of 510 consecutive hospitalized HIV/AIDS patients were included in the study after screening 640 such patients \[[Figure 1](#F1){ref-type="fig"}\]. Dipstick proteinuria of grade ≥1+ was seen in 147 patients (29% of total). 24-hour urinary protein estimation was done in all these patients. Only 15 patients (10.2%) had proteinuria \>1 g/day, and they were eligible for kidney biopsy. However, renal biopsy could not be done in five patients, as two patients didn't consent and urinary tract infection, contracted kidney, and single kidney was observed in one each patient.

![Flow chart showing the study plan. \*defined as dipstick proteinuria ≥1 + and/or serum creatinine ≥1.5 mg/dl](JFMPC-8-860-g001){#F1}

Renal histopathology {#sec2-5}
--------------------

Renal biopsy was studied by light microscopy in 10 patients \[[Table 1](#T1){ref-type="table"}\]. The classical HIV associated nephropathy (HIVAN) was seen in two patients (20%). [Figure 2](#F2){ref-type="fig"} shows a classic case of HIVAN, with features of collapsing FSGS (focal segmental glomerulosclerosis), microcystic tubular dilatation, tubules filled with cast and interstitial infiltrates. Most common glomerular lesion was mesangial proliferative glomerulonephritis (MesPGN), found in 3 cases (30%). Diffuse proliferative glomerulonephritis (DPGN), membranoproliferative glomerulonephritis (MPGN) and diabetic nephropathy were seen in one patient each. [Figure 3](#F3){ref-type="fig"} shows the histopathological features in the patient with MPGN, also known as mesangiocapillary glomerulonephritis. Tubulointerstitial lesions were seen in 2 cases in isolation (CIN, chronic interstitial nephritis), and in 4 cases combined with other glomerular lesions (overall 6 patients, 60%). Ultrasonography of abdomen revealed enlarged kidneys in seven patients (70%), which included both patients of HIVAN.

###### 

Renal histopathology in HIV patients with proteinuria ≥1 gm/day (10 patients)

  Age/sex   Proteinuria   Creatinine   CD4 count   c-ART   Histopathology (predominant lesions)
  --------- ------------- ------------ ----------- ------- --------------------------------------
  34/M      3.8           2.3          108         no      HIVAN with CIN
  28/M      4.2           1.8          38          no      HIVAN
  36/M      2.5           1.6          230         yes     Diabetic nephropathy with IN
  26/F      1.4           0.9          178         yes     Focal MesPGN with IN
  41/M      3.9           1.2          310         no      Focal MesPGN
  32/F      2.1           2.5          325         yes     Diffuse MesPGN
  27/F      1.1           0.8          140         yes     MPGN with CIN
  33/M      2.3           1.3          258         no      DPGN
  22/M      1.7           3.4          48          no      CIN
  29/F      2.3           2.6          122         yes     CIN

cART: Combination anti-retroviral therapy; Mes PGN: Mesangioproliferative glomerulonephritis; MPGN: Membranoproliferative glomerulonephritis; DPGN: Diffuse proliferative glomerulonephritis; MN: Membranous nephropathy; IN: Interstitial nephritis; CIN: Chronic interstitial nephritis; HIVAN: Human immunodeficiency virus associated nephropathy

![Classical features of HIVAN a) collapsing focal segmental glomerular sclerosis (H and E × 400); b) Showing microcystic dilatation of tubules. These tubules are filled with the hyaline cast. (H and E × 400)](JFMPC-8-860-g002){#F2}

![Histopathology in MPGN a) severe GBM thickening and its duplication along with proliferation (PAS × 400); b) increased leucocyte, mesangial cell proliferation, and heavy subendothelial and mesangial deposits. (AFOG × 400)](JFMPC-8-860-g003){#F3}

Discussion {#sec1-4}
==========

We have presented a single center, observational study on histological spectrum of renal disease in HIV/AIDS patients. Renal histopathology in 1o patients with proteinuria ≥1 g/day has been described with particular attention towards presence of HIVAN.

HIVAN is associated with characteristic glomerular, tubulointerstitial, and ultrastructural lesions. The most consistent findings include collapsing FSGS, cystic tubular dilatation, interstitial infiltrates, and dilated tubules filled with proteinaceous casts. Immunofluorescence is nonspecific and ultrastructural changes on electron microscopy are not unique to HIVAN.\[[@ref16]\] The pathogenesis of HIVAN involves local infection of the kidney, systemic HIV infection and systemic immune dysfunction.\[[@ref17]\] Patients with HIVAN typically present with nephrotic range proteinuria and rapidly progressive renal insufficiency, accompanied by varying degrees of azotemia.\[[@ref18]\] Most patients with HIVAN are young men (mean age 33 years; male to female ratio of 10:1) and \>90% of patients are Blacks.\[[@ref19][@ref20]\] HIVAN is associated with large echogenic kidneys, but this relation is non-specific.\[[@ref21]\] Both of our patients with HIVAN were young males presenting with nephrotic range proteinuria, CD4 count \<200 cells/mm^3^ and large echogenic kidneys on ultrasound. The absence of both nephrotic range proteinuria and CD4 count \<200 cells/mm^3^, are useful to exclude diagnosis of HIVAN, with a negative predictive value of 90%.\[[@ref22]\] However, HIVAN can be definitively diagnosed only by kidney biopsy.\[[@ref6]\]

The distribution of HIVAN is not uniform and the true prevalence is not known, mainly due to relatively infrequent kidney biopsies. In an autopsy study of HIV-infected persons the overall prevalence of HIVAN was 6.9%.\[[@ref23]\] Screening study for HIVAN in HIV patients with proteinuria \>1.5 g/day found an overall prevalence of 3.5%.\[[@ref24]\] Prevalence of HIVAN in kidney biopsy series outside India have reported prevalence of HIVAN ranging from 0% to 83% \[[Table 2](#T2){ref-type="table"}\].\[[@ref7][@ref25][@ref26][@ref27][@ref28][@ref29][@ref30][@ref31][@ref32][@ref33]\] HIVAN has been consistently and frequently reported in studies from North America, Western Europe and African countries. However, studies from Italy and Thailand have shown complete absence of this entity.\[[@ref7][@ref32]\] The prevalence of HIVAN in our study was 20%, with the most common glomerular lesion being mesangioproliferative glomerulonephritis (30%) \[[Table 1](#T1){ref-type="table"}\]. MesPGN is an inconsistent finding American, African, and European studies, but represents a substantial proportion in Asia accounting for 1/3^rd^ to 2/3^rd^ of all renal lesions.\[[@ref7][@ref10]\] The probable cause of this discrepancy may lie in racial predisposition, viral genotype, environmental factors, and host susceptibility factors. On the contrary, tubulointerstitial lesions are consistently seen in all kidney biopsy series across world, and may be present in up to 70% cases.\[[@ref12][@ref13][@ref30][@ref33]\]

###### 

Prevalence of HIVAN in kidney biopsies of HIV/AIDS patients in major studies across world

  Study                         Region     Year   No. of cases   Prevalence of HIVAN
  ----------------------------- ---------- ------ -------------- ---------------------
  D'agati et al. (63)           USA        1997   112            64.7%
  Szczech et al. (28)           USA        2002   89             47.2%
  Berliner et al. (64)          USA        2008   152            35%
  Gerntholtz et al. (65)        S Africa   2006   104            27%
  Han et al. (66)               S Africa   2006   30             83%
  Nochy et al. (67)             France     1993   60             43%
  Gutiérrez et al. (68)         Spain      2007   27             14.8%
  Williams et al. (69)          London     1998   17             40%
  Casanova et al. (66)          Italy      1995   26             None
  Cavalcante et al. (29)        Brazil     2007   6              50%
  Praditpornsilpa et al. (17)   Thailand   1999   26             None
  Present Study                 India             10             20%

HIVAN: Human immunodeficiency virus associated nephropathy

Kidney biopsy series in HIV patients from India, have reported wide variability in prevalence of HIVAN, ranging from 0% to 85% \[[Table 3](#T3){ref-type="table"}\].\[[@ref8][@ref9][@ref10][@ref11][@ref12][@ref13][@ref34][@ref35]\] These widely variable results emphasize limitations on drawing conclusions from single-center studies with small sample sizes. Therefore, we did a systemic review of literature on kidney biopsy in adult HIV patients from India. Search was made on Pubmed, Scopus, and Google Scholar, excluding case reports. We pooled biopsy data from all the 10 available biopsy series (including the current study). Among 194 patients, the most frequent glomerular lesion was HIVAN (16.5%) followed by MesPGN (13.9%) and FSGS in 7.7%. Pooling of studies though has obvious limitations, gives a fair degree of insight into the histological spectrum. The current study and pooled analysis show that HIVAN, though less common than Western countries, still has an appreciable prevalence in HIV patients from India. This is in contrast to popular belief that HIVAN is rare in Asian countries. Urinalysis should therefore be done in all HIV/AIDS patients and quantification of proteinuria should be performed wherever feasible.\[[@ref2]\] Kidney biopsy, being the only definite way to diagnose HIVAN, must be done in all patients with significant proteinuria. Diagnosis of HIVAN is very essential as it carries both prognostic and therapeutic implications. Several studies have reported significant improvements in renal function and proteinuria for patients with HIVAN receiving cART, corticosteroids, and ACE inhibition.\[[@ref6]\]

###### 

Renal histopathology in HIV/AIDS patients in Indian studies

  Study                            Year   No. of cases   Renal Histopathology
  -------------------------------- ------ -------------- ------------------------------------------------------------------
  Madiwale (72)                    1999   20             HIVAN 85%, MPGN 5%, MCD 5%, Lupus Nephritis 5%
  Varma et al.(20)                 2000   25             Mes PGN (32%), FSGS (16%), HIVAN (4%)
  Janakiraman et al. (21)          2008   10             HIVAN 70%, DPGN 10%, MN 10%, CIN 10%
  Vali et al. (19)                 2012   27             HIVAN (Collapsing FSGS) 11.1%, FSGS 7.4%, DPGN 7.4%, IN 30%
  Gupta et al. (18)                2013   26             MesPGN 38%, Collapsing FSGS 7%, MPGN 7%, IN 19%
  Sunil et al. (71)                2016   32             HIVAN (6%), MPGN (6%), DN (6%), MesPGN (6%), FSGS (3%), IN (19%)
  Prakash et al. (23)              2017   14             MesPGN 31.2%, FSGS 12.5%, MPGN 12.5%, DPGN 12.5%, IN 71%
  Satish et al. (22)               2018   30             DN 23.3%, FSGS 13.3%, IgAN 10%, DPGN 6.6%, IN 26.6%
  Present Study                           10             MesPGN 30%, HIVAN 20%, MPGN 10%, DPGN 10%, DN 10%, IN 60%
  Pooled analysis\* (10 studies)          194            HIVAN 16.5%, MesPGN 13.9%, FSGS 7.7%, DPGN 4.1%, MPGN 4.1%
                                                         Tubulo-interstitial lesions: 22.7%

Mes PGN: Mesangioproliferative glomerulonephritis; MPGN: Membranoproliferative glomerulonephritis; FSGS: Focal segmental glomerulosclerosis; AIN: Acute interstitial nephritis; DPGN: Diffuse proliferative glomerulonephritis; MN: Membranous nephropathy; CIN: Chronic interstitial nephritis; HIVAN: Human immunodeficiency virus associated nephropathy; MCD: Minimal change disease; DiabeticN : Diabetic nephropathy; IgAN: IgA nephropathy. \*Pooled kidney biopsy data including all observational studies from India

Implication for primary care/family physicians/healthcare professionals {#sec2-6}
-----------------------------------------------------------------------

In view of rising prevalence of renal disorders in HIV/AIDS patients, urinalysis, and estimation of renal function must be done all patients. Contrary to prior belief, HIVAN has an appreciable prevalence in HIV patients with proteinuria in this region. Renal biopsy is recommended wherever feasible, because the treatment options and prognosis are influenced by the actual histological diagnosis.

Study Limitations {#sec2-7}
-----------------

The most important limitation was small number of patients undergoing kidney biopsy. This was because we have limited renal biopsy only to patients with proteinuria ≥1 g/day, as HIVAN most often presents with significant degrees of proteinuria. Second, we have not performed immunofluorescence (IF) and electron microscopy (EM) studies in the biopsy samples. However, this is unlikely to have affected the finding of HIVAN in our study, because its diagnosis is mainly based on light microscopy as IF and EM findings are non-specific.\[[@ref16]\] But, this may have caused failure to detect cases of immune complex diseases. Finally, the results of this study are subject to confounding and bias that are inherent to all observational studies.

Conclusions {#sec1-5}
===========

With improvement in survival due to availability of cART, renal involvement has become quite common in HIV/AIDS patients. Proteinuria as detected by dipstick was present in 29% patients and of this proteinuria ≥1 g/day was seen in 10.2%. We have reported a prevalence of HIVAN in 20% of kidney biopsies. HIVAN is associated with rapid deterioration in renal function and carries a high mortality, but has good response to cART, steroids, and ACE inhibition. Moreover, unlike popular belief, HIVAN appears to be a common entity in this part of world too, and thereby requires a high degree of clinical suspicion. Kidney biopsy, being the only definite way to diagnose HIVAN, must be done in all patients with significant proteinuria.
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